SAN DIEGO--(BUSINESS WIRE)--#earnings--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will report fourth quarter 2022 financial results after the close of the U.S. financial markets on Wednesday,...
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming February 7, 2023 deadline to file a lead plaintiff motion...